FDA
approval
· 2024-02-05
FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Viona Pharmaceuticals Inc)
Summary
FDA approved a supplemental application for Bisoprolol Fumarate and Hydrochlorothiazide from Viona Pharmaceuticals, enabling a new generic combination product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE)